Royal Bank Of Canada Hcw Biologics Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.64 - $1.68 $104 - $273	163 Added 66.8%	407 $0
Q1 2024 Nov 05, 2024	SELL	$1.1 - $1.77 $179 - $288	-163 Reduced 40.05%	244 $0
Q1 2024 May 15, 2024	SELL	$1.1 - $1.77 $57 - $92	-52 Reduced 17.57%	244 $0
Q4 2023 Feb 14, 2024	BUY	$0.92 - $2.14 $272 - $633	296 New	296 $0
Q2 2023 Aug 14, 2023	BUY	$1.35 - $2.3 $190 - $324	141 New	141 $0
Q3 2022 Nov 14, 2022	BUY	$2.13 - $2.74 $272 - $350	128 New	128 $0

1.16M

Ticker HCWB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,833,100
Market Cap $14.7M
Description
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.